Centralized support for blood research projects
Official title: Administrative Core A
Funded at Versiti Wisconsin, INC. · NIH-10934141 · Data updated 2026-11-12
This study is all about helping researchers at the Blood Research Institute work better together on projects related to blood disorders, which could lead to better treatments for patients with autoimmune thrombocytopenias and similar conditions.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Wisconsin, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $176,549 |
| NIH project number | 1P01HL167668-01A1 |
| Project ID | NIH-10934141 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit are individuals diagnosed with autoimmune thrombocytopenias, such as immune thrombocytopenic purpura.
✕Less likely to help
Patients with unrelated blood disorders or those not diagnosed with autoimmune conditions may not receive any benefit from this research.
What this research studies
This research focuses on providing administrative support for various blood-related research projects at the Blood Research Institute in Wisconsin. It aims to enhance collaboration among project leaders and core directors by organizing meetings, maintaining facilities, and overseeing budgetary functions. The initiative is designed to streamline operations and ensure effective communication among researchers involved in studying autoimmune thrombocytopenias and related conditions. Patients may benefit indirectly through improved research outcomes and advancements in treatment protocols.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with autoimmune thrombocytopenias.
How similar studies have gone: Other research initiatives focused on centralized administrative support in medical research have shown success in enhancing project outcomes and collaboration.
Where this research is happening
-
Versiti Wisconsin, INC.
Milwaukee, United States Active
Researchers
- Principal investigator: Newman, Peter J — Versiti Wisconsin, INC.
- Study coordinator: Newman, Peter J
Related research
Other NIH-funded projects on the same topics.
-
Improving blood safety and availability for transfusions in children and adults
This study is looking to make blood transfusions safer and more accessible for both kids and adults by gathering information from blood donors and recipients across the US and Brazil, so that everyone can benefit from better transfusion practices in the future.
-
Understanding how to safely increase fetal hemoglobin for treating blood disorders
This study is looking at how to safely boost fetal hemoglobin levels in people with blood disorders like beta-thalassemia, by exploring new ways to change certain cells in the body, so that patients can have better treatment options.
-
Understanding how certain proteins regulate blood clotting and cardiovascular diseases
This study is looking at how two proteins that help with blood clotting and heart health work, which could lead to better treatments for blood clotting disorders and heart disease.
-
Targeting a specific gene to treat a type of leukemia
This study is testing a new treatment called AI-10-49 for people with acute myeloid leukemia who have a specific genetic change that makes their condition harder to treat, and it aims to help these patients live longer by killing leukemia cells and working better with other medications.
-
Understanding maternal immune responses affecting newborns with low platelet counts
This study is looking at how a mother's immune system can affect her baby's platelets, which might lead to a serious bleeding condition in newborns, and it aims to find out which pregnancies are at higher risk so that better tests and prevention methods can be developed to help keep babies safe.
-
Understanding the immune response in patients with heparin-induced thrombocytopenia
This study is looking at how the immune system responds to heparin, a blood thinner, to find out more about a serious condition called heparin-induced thrombocytopenia (HIT), and it aims to help doctors better identify harmful antibodies in patients, even if their regular tests come back normal, so they can prevent ser
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.